| PUBCHEM ID |
118796437
|
| UNII |
7UP92N11YO
|
| Preferred Term |
3-(ACETYLOXY)-6-(HYDROXYIMINO)CHOLAN-24-OIC ACID METHYL ESTER, (3.ALPHA.,5.BETA.)-
|
| CAS |
59783-88-9
|
| INCHIKEY |
JHIUKMMGUICVJR-BZBJQHDOSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
C[C@@H](CCC(OC)=O)[C@H](CC1)[C@](C)(CC2)[C@H]1[C@@H](/C1)[C@@H]2[C@](C)(CC[C@@H](C2)OC(C)=O)[C@H]2/C1=N/O
|
| Total Surface Area |
351,54
|
| Relative PSA |
0,20109
|
| TPSA |
85,19
|
| cLogS |
-5,843
|
| MW |
461,64
|
| cLogP |
5,7091
|
| H-Acceptors |
6
|
| H-Donors |
1
|
| Ro5 violations |
1
|
| Druglikeness |
-7,3221
|
| DrugScore |
0,1745243178284
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,4743
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Inhibitor
|
| P-glycoprotein Inhibitor II |
Inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
0,8964
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
1,0443
|
| Tetrahymena Pyriformis Toxicity |
High HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,6401
|
| Carcinogenicity (Three-class) |
Non-required
|
